AMGN vs ABT
By Alex · Tickerpine
Amgen Inc. vs Abbott Laboratories, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | AMGN | ABT |
|---|---|---|
| Price | $416.18 | $110.91 |
| Market cap | $225.15B | $191.92B |
| P/E ratio | 25.7 | 35.4 |
| ROE | 91.47% | 10.58% |
| Profit margin | 22.95% | 11.65% |
| Revenue growth | 9.50% | 13.00% |
| Dividend yield | 2.43% | 2.27% |
| Beta | 0.41 | 0.58 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
AMGN vs ABT in plain English
- AMGN and ABT are similar in size.
- AMGN is cheaper on earnings (P/E 25.7 vs 35.4).
- AMGN earns a higher return on equity (91% vs 11%).
- ABT is growing revenue faster (13% vs 10%).
- AMGN has the higher dividend yield (2.43% vs 2.27%).
How would $1,000 have done in each?
AMGN return calculator
See what $1,000 in Amgen Inc. would be worth today.
ABT return calculator
See what $1,000 in Abbott Laboratories would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.